Literature DB >> 1908080

Effect of cost on the self-administration and efficacy of nicotine gum: a preliminary study.

J R Hughes1, W C Wadland, J W Fenwick, J Lewis, W K Bickel.   

Abstract

METHODS. One hundred six smokers seen in a family practice received brief physician advice and a prescription for nicotine gum. Smokers were randomly assigned to pay $20, $6, or $0/box of nicotine gum and followed for 6 months. RESULTS. Decreased cost increased the incidence of obtaining gum, the amount of gum used, and the incidence of long-term use (P less than 0.05). Decreased cost also increased cessation attempts and 1-week cessation (P less than 0.05) and appeared to increase abstinence at 6-month follow-up (19% vs 6% vs 8%, P less than 0.10). Cost-benefit estimates suggest that an insurance plan, HMO, etc., would recoup any costs in subsidizing nicotine gum and perhaps incur a net financial gain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908080     DOI: 10.1016/0091-7435(91)90046-7

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  23 in total

Review 1.  Four beliefs that may impede progress in the treatment of smoking.

Authors:  J R Hughes
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority.

Authors:  M Raw; A McNeill; R West
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

3.  Should smoking cessation cost a packet? A pilot randomized controlled trial of the cost-effectiveness of distributing nicotine therapy free of charge.

Authors:  P Dey; R Foy; M Woodman; B Fullard; A Gibbs
Journal:  Br J Gen Pract       Date:  1999-02       Impact factor: 5.386

Review 4.  A meta-analysis of the efficacy of over-the-counter nicotine replacement.

Authors:  J R Hughes; S Shiffman; P Callas; J Zhang
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

Review 5.  Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage.

Authors:  K E Warner
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

6.  Socioeconomic variations in nicotine dependence, self-efficacy, and intention to quit across four countries: findings from the International Tobacco Control (ITC) Four Country Survey.

Authors:  M Siahpush; A McNeill; R Borland; G T Fong
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

7.  Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped-care and matching model.

Authors:  D B Abrams; C T Orleans; R S Niaura; M G Goldstein; J O Prochaska; W Velicer
Journal:  Ann Behav Med       Date:  1996

8.  Community patterns of transdermal nicotine use and provider counseling.

Authors:  S H Swartz; A J Ellsworth; S J Curry; E J Boyko
Journal:  J Gen Intern Med       Date:  1995-12       Impact factor: 5.128

9.  Evaluating the Impact of Eliminating Copayments for Tobacco Cessation Pharmacotherapy.

Authors:  Kelly C Young-Wolff; Sara R Adams; Daniella Klebaner; Alyce S Adams; Cynthia I Campbell; Derek D Satre; Judith J Prochaska
Journal:  Med Care       Date:  2018-11       Impact factor: 2.983

Review 10.  A review of economic evaluations of tobacco control programs.

Authors:  Jennifer W Kahende; Brett R Loomis; Bishwa Adhikari; Latisha Marshall
Journal:  Int J Environ Res Public Health       Date:  2008-12-28       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.